WHY GLOBAL REAL WORLD EVIDENCE MATTERS
ERT’s Vice President of Trial Oversight, Chief Diversity Officer, and Trial Better podcast host, Otis Johnson, is joined by Jennifer Stacey, Senior Vice President of Clinical Science and Operations at TriNetX for a conversation on real world evidence. They discuss how the non-global nature of real world evidence is changing for the better, and what that means for clinical research going forward.
Access Trial Better Podcast from your favorite channels:
Senior Vice President of Clinical Science and Operations at TriNetX
Jennifer Stacey has 20 years of clinical research experience ranging from biomarker and target discovery to strategic conduction of drug development programs. By leveraging big data with health analytics and informatics, she has provided consultative trial planning, competitive intelligence, and custom project work for over 100 pharmaceutical and contract research organizations. Prior to joining TriNetX, Jennifer held scientific positions at Cell Signaling Technology, Citeline, and inVentiv Health. She received her BS in Biology/Pre-Medicine from St. Lawrence University.